tiprankstipranks
Trending News
More News >
Cannara Biotech, Inc. (LOVFF)
:LOVFF
US Market
Advertisement

Cannara Biotech (LOVFF) Ratios

Compare
12 Followers

Cannara Biotech Ratios

LOVFF's free cash flow for Q2 2025 was C$0.45. For the 2025 fiscal year, LOVFF's free cash flow was decreased by C$ and operating cash flow was C$0.21. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio
2.35 2.44 3.46 2.82 3.03
Quick Ratio
0.93 0.85 1.86 1.73 2.38
Cash Ratio
0.16 0.20 1.02 1.19 2.24
Solvency Ratio
0.30 0.19 0.11 >-0.01 -0.68
Operating Cash Flow Ratio
0.30 0.26 -0.51 -0.31 -2.68
Short-Term Operating Cash Flow Coverage
0.67 0.91 -3.09 -6.90 -30.87
Net Current Asset Value
C$ 7.99MC$ -10.08MC$ -17.89MC$ -8.66MC$ -5.96M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.32 0.39 0.23 0.24
Debt-to-Equity Ratio
0.52 0.57 0.73 0.33 0.34
Debt-to-Capital Ratio
0.34 0.36 0.42 0.25 0.25
Long-Term Debt-to-Capital Ratio
0.26 0.33 0.41 0.24 0.24
Financial Leverage Ratio
1.71 1.77 1.88 1.44 1.43
Debt Service Coverage Ratio
1.27 1.40 2.60 0.89 -6.06
Interest Coverage Ratio
4.40 2.24 1.91 0.12 -9.00
Debt to Market Cap
0.30 0.51 0.41 0.16 0.18
Interest Debt Per Share
0.59 0.57 0.57 0.29 0.20
Net Debt to EBITDA
1.83 2.63 3.80 3.95 -0.56
Profitability Margins
Gross Profit Margin
41.96%47.56%48.36%60.50%48.00%
EBIT Margin
18.36%18.91%12.49%0.22%-461.36%
EBITDA Margin
25.38%27.54%26.62%18.94%-358.62%
Operating Profit Margin
19.85%20.76%10.25%1.13%-467.66%
Pretax Profit Margin
14.42%12.13%6.43%-8.98%-513.33%
Net Profit Margin
14.22%12.13%6.43%-18.18%-541.32%
Continuous Operations Profit Margin
14.22%12.13%6.43%-8.98%-513.33%
Net Income Per EBT
98.61%100.00%100.00%202.49%105.45%
EBT Per EBIT
72.62%58.42%62.78%-793.44%109.77%
Return on Assets (ROA)
8.30%4.91%1.84%-3.36%-25.17%
Return on Equity (ROE)
15.12%8.71%3.45%-4.83%-35.99%
Return on Capital Employed (ROCE)
14.46%9.88%3.23%0.23%-23.22%
Return on Invested Capital (ROIC)
12.83%9.41%3.92%0.45%-24.25%
Return on Tangible Assets
8.30%4.91%1.84%-3.36%-25.25%
Earnings Yield
8.45%7.78%1.95%-2.38%-20.38%
Efficiency Ratios
Receivables Turnover
6.05 5.41 4.16 5.73 8.26
Payables Turnover
4.85 3.38 2.17 1.09 0.48
Inventory Turnover
1.20 0.89 0.98 0.91 0.59
Fixed Asset Turnover
1.09 0.64 0.43 0.24 0.06
Asset Turnover
0.58 0.40 0.29 0.18 0.05
Working Capital Turnover Ratio
2.36 1.92 1.73 1.75 0.17
Cash Conversion Cycle
288.20 370.01 293.73 129.82 -97.13
Days of Sales Outstanding
60.29 67.52 87.76 63.65 44.17
Days of Inventory Outstanding
303.16 410.49 374.25 402.27 616.86
Days of Payables Outstanding
75.25 108.00 168.28 336.10 758.16
Operating Cycle
363.45 478.01 462.01 465.92 661.04
Cash Flow Ratios
Operating Cash Flow Per Share
0.11 0.06 -0.07 -0.03 -0.13
Free Cash Flow Per Share
0.04 -0.05 -0.25 -0.43 -0.25
CapEx Per Share
0.07 0.11 0.18 0.41 0.12
Free Cash Flow to Operating Cash Flow
0.36 -0.82 3.54 15.85 1.95
Dividend Paid and CapEx Coverage Ratio
1.56 0.55 -0.39 -0.07 -1.06
Capital Expenditure Coverage Ratio
1.56 0.55 -0.39 -0.07 -1.06
Operating Cash Flow Coverage Ratio
0.20 0.12 -0.13 -0.10 -0.72
Operating Cash Flow to Sales Ratio
0.10 0.09 -0.17 -0.12 -3.66
Free Cash Flow Yield
2.19%-4.97%-18.20%-25.50%-26.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.83 12.86 51.34 -42.04 -4.91
Price-to-Sales (P/S) Ratio
1.70 1.56 3.30 7.64 26.57
Price-to-Book (P/B) Ratio
1.68 1.12 1.77 2.03 1.77
Price-to-Free Cash Flow (P/FCF) Ratio
45.68 -20.10 -5.49 -3.92 -3.74
Price-to-Operating Cash Flow Ratio
16.23 16.42 -19.47 -62.15 -7.27
Price-to-Earnings Growth (PEG) Ratio
0.11 0.07 -0.31 0.53 0.98
Price-to-Fair Value
1.68 1.12 1.77 2.03 1.77
Enterprise Value Multiple
8.52 8.29 16.21 44.30 -7.97
Enterprise Value
203.81M 130.81M 154.63M 142.81M 72.93M
EV to EBITDA
8.52 8.29 16.21 44.30 -7.97
EV to Sales
2.16 2.28 4.31 8.39 28.59
EV to Free Cash Flow
58.18 -29.45 -7.18 -4.31 -4.02
EV to Operating Cash Flow
20.87 24.06 -25.44 -68.24 -7.82
Tangible Book Value Per Share
1.04 0.89 0.76 0.84 0.54
Shareholders’ Equity Per Share
1.04 0.89 0.76 0.84 0.54
Tax and Other Ratios
Effective Tax Rate
0.01 0.00 -0.24 -1.02 -0.05
Revenue Per Share
1.04 0.64 0.41 0.22 0.04
Net Income Per Share
0.15 0.08 0.03 -0.04 -0.19
Tax Burden
0.99 1.00 1.00 2.02 1.05
Interest Burden
0.79 0.64 0.51 -40.15 1.11
Research & Development to Revenue
<0.01 0.02 0.04 0.11 1.02
SG&A to Revenue
0.10 0.19 0.24 0.36 3.16
Stock-Based Compensation to Revenue
0.01 0.03 <0.01 0.02 0.31
Income Quality
0.73 0.78 -2.64 1.37 0.71
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis